Compare Organon & Co. Common Stock (OGN) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Utilities Select Sector SPDR Fund — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Utilities Select Sector SPDR Fund trades at $41.88 (market cap $24.20B). The key difference: Utilities Select Sector SPDR Fund is far larger — about 6.7× Organon & Co. Common Stock's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Utilities Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Utilities Select Sector SPDR Fund for 81 Days on average.
| OGN | XLU | |
|---|---|---|
Market Cap | $3.62B | $24.20B |
Volume | 2,892,999 | 27,226,247 |
Sector | Health | — |
52-Week High | $13.81 | $47.73 |
52-Week Low | $5.70 | $39.25 |
Typical Hold Time | 0 Days | 81 Days |
Enterprise Value | $11.04B | — |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
XLU trades at $41.87, up 0.58% on the day, but remains under pressure after hitting recent 52-week lows near $39.13. Technical indicators show mixed signals with a bullish moving average trend but bearish oscillators, including an overbought RSI. The utilities sector faces headwinds from rising interest rates and regulatory challenges, particularly affecting data-center demand growth.
The outlook remains cautious as utility stocks face macro pressures from interest rates and regulatory uncertainty. While defensive characteristics provide some stability, near-term performance depends on interest rate direction and AI power demand evolution. Risk-reward appears balanced with potential for recovery if macro conditions stabilize.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
